Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• PSMA (prostate-specific membrane antigen) PET scan
• Whole body MRI
• Isotope bone scan
• One-stop diagnostic clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Psychological counselling

For Wales, this data completeness relates to patients diagnosed between April 2022 and March 2023.
For England, this data completeness relates to patients diagnosed in 2021. This is the data completeness of the National Cancer Registration Dataset (NCRD). For data completeness of the Rapid Cancer Registration Dataset (RCRD), please refer to the NPCA quarterly reports.

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	185	1108
Performance Status recorded	93%	89%
PSA completed	97%	89%
Gleason Score completed	72%	84%
TNM completed	92%	86%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men with disease status determined	1044	39897
Percentage of men diagnosed with metastatic disease	17%	17%

For Wales, these results relate to patients diagnosed between April 2022 and March 2023.
For England, these results relate to patients diagnosed between January and December 2021.

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	156	4684
Percentage of men with low-risk localised disease receiving radical treatment	4%	8%
No. of men diagnosed with locally advanced disease	354	15410
Percentage of men diagnosed with locally advanced disease receiving radical treatment	65%	68%